Exchange: NYSE·Updated 07:30 PM EST

INSP Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 02

Estimated EPS

$0.09

Reported EPS

$0.14

Surprise

+60.9%

Estimated Rev

$204.31M

Reported Rev

$206.7M

Surprise

+1.17%

• Reported GAAP EPS of $0.14 down -62.16% YoY • Reported revenue of $206.69M down -7.93% YoY • Inspire Medical Systems expects Full Year 2026 revenue of $850M to $860M, adjusted operating margin of 4.5% to 5.5%, diluted EPS of -$0.36 to -$0.1, and adjusted diluted EPS of $1.2 to $1.4.

Bullish Takeaway

Inspire Medical Systems reported sequential growth and U.S. performance ahead of expectations, gross margin increased with increased Inspire V sales mix, and a new Category I CPT code is approved for 2028.

Bearish Takeaway

Inspire Medical Systems' revenue decreased amid coding and reimbursement challenges, operating expenses increased with restructuring and legal costs, and operating cash flow was $46.4M versus $68.5M.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
$0.91
--
--
N/A
Q3 '26
$0.09
$0.14
60.90%
BEAT
Q2 '26
-$0.24
$0.14
159.34%
BEAT
Q1 '26
-$0.28
$0.10
136.32%
BEAT
Q4 '25
$0.68
$1.65
143.88%
BEAT

Advertisement|Remove ads.